Compare ATRA & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRA | RGT |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.2M | 94.4M |
| IPO Year | 2014 | N/A |
| Metric | ATRA | RGT |
|---|---|---|
| Price | $9.45 | $14.27 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | ★ 36.6K | 10.6K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ 122.52 | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $120,772,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,334.59 | N/A |
| P/E Ratio | ★ N/A | $15.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $12.01 |
| 52 Week High | $19.15 | $15.79 |
| Indicator | ATRA | RGT |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 38.78 |
| Support Level | $8.96 | $13.97 |
| Resistance Level | $11.22 | $14.84 |
| Average True Range (ATR) | 0.67 | 0.19 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 79.08 | 12.68 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Royce Global Value Trust Inc is a diversified closed-end investment company. The Fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples and energy. Geographically, it has presence in the United Kingdom, Japan, the United States, Canada, France, Hong Kong and Germany.